These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 26064451)

  • 1. Fatty acid metabolism in pulmonary arterial hypertension: role in right ventricular dysfunction and hypertrophy.
    Talati M; Hemnes A
    Pulm Circ; 2015 Jun; 5(2):269-78. PubMed ID: 26064451
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Shifts in myocardial fatty acid and glucose metabolism in pulmonary arterial hypertension: a potential mechanism for a maladaptive right ventricular response.
    Ohira H; deKemp R; Pena E; Davies RA; Stewart DJ; Chandy G; Contreras-Dominguez V; Dennie C; Mc Ardle B; Mc Klein R; Renaud JM; DaSilva JN; Pugliese C; Dunne R; Beanlands R; Mielniczuk LM
    Eur Heart J Cardiovasc Imaging; 2016 Dec; 17(12):1424-1431. PubMed ID: 26060207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fatty Acid Metabolic Defects and Right Ventricular Lipotoxicity in Human Pulmonary Arterial Hypertension.
    Brittain EL; Talati M; Fessel JP; Zhu H; Penner N; Calcutt MW; West JD; Funke M; Lewis GD; Gerszten RE; Hamid R; Pugh ME; Austin ED; Newman JH; Hemnes AR
    Circulation; 2016 May; 133(20):1936-44. PubMed ID: 27006481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms of Lipid Accumulation in the Bone Morphogenetic Protein Receptor Type 2 Mutant Right Ventricle.
    Talati MH; Brittain EL; Fessel JP; Penner N; Atkinson J; Funke M; Grueter C; Jerome WG; Freeman M; Newman JH; West J; Hemnes AR
    Am J Respir Crit Care Med; 2016 Sep; 194(6):719-28. PubMed ID: 27077479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. l-Carnitine therapy improves right heart dysfunction through Cpt1-dependent fatty acid oxidation.
    Agrawal V; Hemnes AR; Shelburne NJ; Fortune N; Fuentes JL; Colvin D; Calcutt MW; Talati M; Poovey E; West JD; Brittain EL
    Pulm Circ; 2022 Jul; 12(3):e12107. PubMed ID: 35911183
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PPARγ agonist pioglitazone reverses pulmonary hypertension and prevents right heart failure via fatty acid oxidation.
    Legchenko E; Chouvarine P; Borchert P; Fernandez-Gonzalez A; Snay E; Meier M; Maegel L; Mitsialis SA; Rog-Zielinska EA; Kourembanas S; Jonigk D; Hansmann G
    Sci Transl Med; 2018 Apr; 10(438):. PubMed ID: 29695452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. With No Lysine Kinase 1 Promotes Metabolic Derangements and RV Dysfunction in Pulmonary Arterial Hypertension.
    Prisco SZ; Eklund M; Raveendran R; Thenappan T; Prins KW
    JACC Basic Transl Sci; 2021 Nov; 6(11):834-850. PubMed ID: 34869947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment Targets for Right Ventricular Dysfunction in Pulmonary Arterial Hypertension.
    Prisco SZ; Thenappan T; Prins KW
    JACC Basic Transl Sci; 2020 Dec; 5(12):1244-1260. PubMed ID: 33426379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolism and bioenergetics in the right ventricle and pulmonary vasculature in pulmonary hypertension.
    Archer SL; Fang YH; Ryan JJ; Piao L
    Pulm Circ; 2013 Jan; 3(1):144-52. PubMed ID: 23662191
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fischer rats exhibit maladaptive structural and molecular right ventricular remodelling in severe pulmonary hypertension: a genetically prone model for right heart failure.
    Suen CM; Chaudhary KR; Deng Y; Jiang B; Stewart DJ
    Cardiovasc Res; 2019 Mar; 115(4):788-799. PubMed ID: 30357319
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitochondrial metabolic adaptation in right ventricular hypertrophy and failure.
    Piao L; Marsboom G; Archer SL
    J Mol Med (Berl); 2010 Oct; 88(10):1011-20. PubMed ID: 20820751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased in vivo mitochondrial oxygenation with right ventricular failure induced by pulmonary arterial hypertension: mitochondrial inhibition as driver of cardiac failure?
    Balestra GM; Mik EG; Eerbeek O; Specht PA; van der Laarse WJ; Zuurbier CJ
    Respir Res; 2015 Feb; 16(1):6. PubMed ID: 25645252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contribution of Impaired Parasympathetic Activity to Right Ventricular Dysfunction and Pulmonary Vascular Remodeling in Pulmonary Arterial Hypertension.
    da Silva Gonçalves Bós D; Van Der Bruggen CEE; Kurakula K; Sun XQ; Casali KR; Casali AG; Rol N; Szulcek R; Dos Remedios C; Guignabert C; Tu L; Dorfmüller P; Humbert M; Wijnker PJM; Kuster DWD; van der Velden J; Goumans MJ; Bogaard HJ; Vonk-Noordegraaf A; de Man FS; Handoko ML
    Circulation; 2018 Feb; 137(9):910-924. PubMed ID: 29167228
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular mechanisms of right ventricular dysfunction in pulmonary arterial hypertension: focus on the coronary vasculature, sex hormones, and glucose/lipid metabolism.
    Agrawal V; Lahm T; Hansmann G; Hemnes AR
    Cardiovasc Diagn Ther; 2020 Oct; 10(5):1522-1540. PubMed ID: 33224772
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A potential adverse role for leptin and cardiac leptin receptor in the right ventricle in pulmonary arterial hypertension: effect of metformin is BMPR2 mutation-specific.
    Talati M; Brittain E; Agrawal V; Fortune N; Simon K; Shay S; Zeng X; Freeman ML; West J; Hemnes A
    Front Med (Lausanne); 2023; 10():1276422. PubMed ID: 37869164
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Colchicine Depolymerizes Microtubules, Increases Junctophilin-2, and Improves Right Ventricular Function in Experimental Pulmonary Arterial Hypertension.
    Prins KW; Tian L; Wu D; Thenappan T; Metzger JM; Archer SL
    J Am Heart Assoc; 2017 May; 6(6):. PubMed ID: 28566298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanistic Phase II Clinical Trial of Metformin in Pulmonary Arterial Hypertension.
    Brittain EL; Niswender K; Agrawal V; Chen X; Fan R; Pugh ME; Rice TW; Robbins IM; Song H; Thompson C; Ye F; Yu C; Zhu H; West J; Newman JH; Hemnes AR
    J Am Heart Assoc; 2020 Nov; 9(22):e018349. PubMed ID: 33167773
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pulmonary arterial hypertension reduces energy efficiency of right, but not left, rat ventricular trabeculae.
    Pham T; Nisbet L; Taberner A; Loiselle D; Han JC
    J Physiol; 2018 Apr; 596(7):1153-1166. PubMed ID: 29363144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological Inhibition of mTOR Kinase Reverses Right Ventricle Remodeling and Improves Right Ventricle Structure and Function in Rats.
    Pena A; Kobir A; Goncharov D; Goda A; Kudryashova TV; Ray A; Vanderpool R; Baust J; Chang B; Mora AL; Gorcsan J; Goncharova EA
    Am J Respir Cell Mol Biol; 2017 Nov; 57(5):615-625. PubMed ID: 28679058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Different mechanisms for changes in glucose uptake of the right and left ventricular myocardium in pulmonary hypertension.
    Kluge R; Barthel H; Pankau H; Seese A; Schauer J; Wirtz H; Seyfarth HJ; Steinbach J; Sabri O; Winkler J
    J Nucl Med; 2005 Jan; 46(1):25-31. PubMed ID: 15632029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.